Ascendis Pharma A/S (NASDAQ:ASND) Stock Price Expected to Rise, Evercore ISI Analyst Says
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) had its target price hoisted by equities research analysts at Evercore ISI from $220.00 to $260.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Evercore ISI’s target price would suggest a potential upside of 67.62% […]
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) had its target price hoisted by equities research analysts at Evercore ISI from $220.00 to $260.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Evercore ISI’s target price would suggest a potential upside of 67.62% […]
